Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset in the wake ...

The Advocate highlights social inequality through original stories and opinions, and content generated by fellow NNPA and other publications ...

The Centers for Disease Control and Prevention was rocked by five high-level departures on Tuesday in the latest turmoil for the nation’s top public health agency. The departures were announced at a ...